Effects of curcumin on reflux esophagitis in rats
- 109 Downloads
The preventive effect of curcumin, a compound isolated from the rhizome of Curcuma longa, on experimental reflux esophagitis in rats was investigated in order to validate its potential therapeutic use for gastroesophageal reflux disease. Curcumin (20 mg/kg, i.d.), the antioxidative agent dimethyl sulfoxide (DMSO) (1 ml/kg, i.p.) or the proton pump inhibitor lansoprazole (1 mg/kg, i.d.) inhibited the formation of acute acid reflux esophagitis by 52.5, 61.5 and 70.9% respectively. Curcumin alone was not effective in preventing chronic acid reflux esophagitis, but the combination of curcumin and DMSO reduced the mortality rate and the severity of the esophagitis ulcer index to the same extent (56.5%) as did the lansoprazole (53.9%). Intraduodenal administration of curcumin also markedly prevented the formation of acute mixed reflux esophagitis, together with reducing the incidence or the severity of neutrophil infiltration, when compared to a control group. In contrast, lansoprazole tended to increase the severity of all histopathological changes, when compared to either the control or the curcumin-treated group. Aminoguanidine, a specific inducible nitric oxide synthase inhibitor, had no preventive effect against both types of acute reflux esophagitis models, and increased the mortality in the chronic acid reflux esophagitis model. From these results, it is indicated that curcumin can effectively prevent acute reflux esophagitis formation. Although curcumin is less potent than lansoprazole in inhibiting acid reflux esophagitis, it is superior to lansoprazole in inhibiting mixed reflux esophagitis. The antiulcerogenic mechanisms are considered to be closely associated with its antioxidant nature and antiinflammatory property.
KeywordsCurcumin Acid reflux esophagitis Mixed reflux esophagitis Preventive action
The authors are grateful to Graduate School, Prince of Songkla University and Ministry of University Affairs, Thailand for financial support of this work. We thank Dr. Brian Hodgson for correction and improvement of the manuscript.
- 12.Sinha M, Mukherjee BP, Mukherjee B, Sikdar S, Dasgupta SR (1975) Study of the mechanism of action of curcumin: an antiulcer agent. Ind J Pharmacol 7:98Google Scholar
- 14.Roughley PJ, Whiting DA (1973) Experiments in the biosynthesis of curcumin. J Chem Soc 40:3741–3746Google Scholar
- 18.Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, Maki Y (1989) Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharm Exp Ther 248:806–815Google Scholar
- 28.Lee JS, Oh TY, Ahn BO, Cho H, Kim WB, Kim YB, Surh YJ, Kim HJ, Hahm KB (2001) Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett’s esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res 480–481:189–200CrossRefPubMedGoogle Scholar
- 29.Tomatsuri N, Yoshida N, Takayama T, Yamaguchi T, Takagi T, Handa O, Ishikawa T, Matsumoto N, Ochiai J, Naito Y, Yoshikawa T (2001) Role of neutrophils and cytokines in esophagitis induced by reflux of gastro-duodenal contents. Ulcer Res 28:85–87Google Scholar